| |
|
|
| Name: |
BVF INC/IL |
| City: |
SAN FRANCISCO |
| State: |
CA |
| Zip: |
94104 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
46 |
|
View All Holdings |
Currently
Viewing:
Unchanged Positions |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
MLTX |
Multisys Language Solutions... |
1 |
- |
$0.00 |
$1,313,560,000 |
21,751,284 |
32.87% |
73,737,000 |
0 |
52.927 |
N/A |
|
|
PTGX |
Protagonist Therapeutics, Inc |
4 |
- |
$27.11 |
$131,729,000 |
5,744,848 |
3.3% |
35,905,000 |
0 |
10.22 |
N/A |
|
|
MIRM |
Mirum Pharmaceuticals, Inc. |
6 |
- |
$0.00 |
$129,003,000 |
4,370,024 |
3.23% |
-9,090,000 |
0 |
11.853 |
N/A |
|
|
OLMA |
Olema Pharmaceuticals, Inc. |
7 |
- |
$0.00 |
$128,177,000 |
9,135,893 |
3.21% |
15,349,000 |
0 |
22.743 |
N/A |
|
|
FDMT |
4d Molecular Therapeutics Inc. |
10 |
- |
$0.00 |
$81,190,000 |
4,007,413 |
2.03% |
30,176,000 |
0 |
12.372 |
N/A |
|
|
GLPG |
Galapagos NV - ADR |
11 |
- |
$29.03 |
$77,849,000 |
1,915,109 |
1.95% |
11,682,000 |
0 |
2.931 |
N/A |
|
|
MRUS |
Merus Nv |
12 |
- |
$47.09 |
$75,692,000 |
2,752,420 |
1.89% |
10,790,000 |
0 |
6.45 |
N/A |
|
|
XOMA |
XOMA Corporation |
16 |
- |
$24.20 |
$67,224,000 |
3,633,743 |
1.68% |
16,025,000 |
0 |
32.243 |
Biotechnology |
|
|
ZYME |
Zymeworks Inc |
18 |
- |
$9.06 |
$60,989,000 |
5,870,000 |
1.53% |
23,773,000 |
0 |
9.188 |
N/A |
|
|
EPIX |
ESSA Pharma Inc |
20 |
- |
$0.00 |
$57,741,000 |
8,748,629 |
1.45% |
30,708,000 |
0 |
19.892 |
Diagnostic Substances |
|
|
JANX |
Janux Therapeutics, Inc. |
21 |
- |
$0.00 |
$49,141,000 |
4,579,818 |
1.23% |
2,976,000 |
0 |
11.478 |
N/A |
|
|
THRD |
Third Harmonic Bio, Inc. |
22 |
- |
$11.79 |
$47,894,000 |
4,365,933 |
1.2% |
19,996,000 |
0 |
10.769 |
N/A |
|
|
TYRA |
Tyra Biosciences, Inc. |
27 |
- |
$0.00 |
$37,943,000 |
2,739,595 |
0.95% |
219,000 |
0 |
6.638 |
N/A |
|
|
CGEM |
Cullinan Oncology Ord Shs |
30 |
- |
$0.00 |
$32,574,000 |
3,196,701 |
0.82% |
3,644,000 |
0 |
7.345 |
N/A |
|
|
ANTX |
An2 Therapeutics Ord Shs |
31 |
- |
$2.44 |
$32,046,000 |
1,563,963 |
0.8% |
6,897,000 |
0 |
8.058 |
N/A |
|
|
ROIV |
Roivant Sciences Ltd. |
33 |
- |
$11.21 |
$30,797,000 |
2,742,409 |
0.77% |
-1,234,000 |
0 |
0.396 |
N/A |
|
|
SLN |
Silence Therapeutics Adr Re... |
34 |
- |
$0.00 |
$26,201,000 |
1,508,416 |
0.66% |
11,373,000 |
0 |
5.06 |
N/A |
|
|
ALLK |
Allakos Inc. |
35 |
- |
$1.26 |
$23,348,000 |
8,552,417 |
0.58% |
3,934,000 |
0 |
10.037 |
N/A |
|
|
GLYC |
Glycomimetics Inc |
36 |
- |
$0.30 |
$22,524,000 |
9,544,262 |
0.56% |
8,208,000 |
0 |
19.955 |
N/A |
|
|
OVID |
Ovid Therapeutics Inc. |
37 |
- |
$3.09 |
$22,060,000 |
6,851,051 |
0.55% |
-4,248,000 |
0 |
10.799 |
N/A |
|
|
CALT |
Calliditas Therapeutics Ab |
39 |
- |
$0.00 |
$19,328,000 |
750,000 |
0.48% |
5,633,000 |
0 |
3.004 |
N/A |
|
|
TCRX |
Tscan Therapeutics, Inc. |
40 |
- |
$0.00 |
$17,429,000 |
2,989,474 |
0.44% |
9,776,000 |
0 |
16.055 |
N/A |
|
|
NAMS |
Newamsterdam Pharma Ord Shs |
41 |
- |
$0.00 |
$17,000,000 |
1,521,948 |
0.43% |
2,922,000 |
0 |
1.866 |
N/A |
|
|
STRO |
Sutro Biopharma Inc |
43 |
- |
$4.28 |
$14,363,000 |
3,347,946 |
0.36% |
2,746,000 |
0 |
5.947 |
N/A |
|
|
ITOS |
Iteos Therapeutics, Inc. |
44 |
- |
$0.00 |
$13,791,000 |
1,259,476 |
0.35% |
0 |
0 |
3.318 |
N/A |
|
|
VSTM |
Verastem, Inc. |
45 |
- |
$11.40 |
$13,718,000 |
1,685,219 |
0.34% |
17,000 |
0 |
6.679 |
Biotechnology |
|
|
IMVT |
Immunovant Inc |
46 |
- |
$0.00 |
$12,639,000 |
300,000 |
0.32% |
1,122,000 |
0 |
0.345 |
N/A |
|
|
CTMX |
Cytomx Therapeutics, Inc. |
48 |
- |
$0.00 |
$10,223,000 |
6,595,801 |
0.26% |
1,714,000 |
0 |
10.123 |
N/A |
|
|
VERV |
Verve Therapeutics, Inc. |
50 |
- |
$0.00 |
$9,061,000 |
650,000 |
0.23% |
442,000 |
0 |
0.978 |
N/A |
|
|
ELDN |
Eledon Pharmaceuticals Ord Shs |
51 |
- |
$2.44 |
$7,788,000 |
4,326,710 |
0.19% |
1,860,000 |
0 |
30.236 |
N/A |
|
|
VIGL |
Vigil Neuroscience, Inc. |
53 |
- |
$0.00 |
$6,130,000 |
1,813,633 |
0.15% |
-3,645,000 |
0 |
6.415 |
N/A |
|
|
CDTX |
Cidara Therapeutics, Inc. |
54 |
- |
$0.00 |
$5,448,000 |
6,861,127 |
0.14% |
-1,017,000 |
0 |
15.615 |
N/A |
|
|
RAIN |
Rain Therapeutics Inc. |
55 |
- |
$0.00 |
$4,232,000 |
3,526,729 |
0.11% |
1,193,000 |
0 |
13.303 |
N/A |
|
|
DCTH |
Delcath Systems Inc |
56 |
- |
$5.52 |
$4,061,000 |
976,149 |
0.1% |
108,000 |
0 |
15.087 |
Research Services |
|
|
PIRS |
Pieris Pharmaceuticals, Inc. |
57 |
- |
$0.15 |
$3,751,000 |
20,609,863 |
0.09% |
-2,391,000 |
0 |
36.823 |
N/A |
|
|
KRON |
Kronos Bio, Inc. |
58 |
- |
$0.00 |
$3,631,000 |
2,905,043 |
0.09% |
-146,000 |
0 |
5.185 |
N/A |
|
|
NLSP |
Nls Pharmaceutics Ord Shs |
59 |
- |
$0.00 |
$3,390,000 |
5,747,126 |
0.08% |
-581,000 |
0 |
47.615 |
N/A |
|
|
IVA |
Inventiva Adr Representing ... |
60 |
- |
$3.44 |
$3,073,000 |
686,040 |
0.08% |
192,000 |
0 |
1.787 |
N/A |
|
|
FBRX |
Forte Biosciences Inc |
61 |
- |
$1.26 |
$2,450,000 |
2,982,105 |
0.06% |
476,000 |
0 |
23.243 |
N/A |
|
|
CRVS |
Corvus Pharmaceuticals, Inc. |
62 |
- |
$1.96 |
$2,413,000 |
1,370,947 |
0.06% |
411,000 |
0 |
4.889 |
N/A |
|
|
VIRX |
Viracta Therapeutics Ord Shs |
63 |
- |
$0.82 |
$2,060,000 |
3,614,662 |
0.05% |
-1,699,000 |
0 |
9.746 |
Biotechnology |
|
|
MTEM |
Molecular Templates, Inc. |
64 |
- |
$0.60 |
$1,969,000 |
532,038 |
0.05% |
-1,393,000 |
0 |
0.949 |
Diagnostic Substances |
|
|
MOLN |
Molecular Partners Adr |
66 |
- |
$0.00 |
$1,764,000 |
443,221 |
0.04% |
-4,000 |
0 |
1.373 |
N/A |
|
|
ELEV |
Elevation Oncology, Inc. |
67 |
- |
$3.58 |
$1,242,000 |
2,312,200 |
0.03% |
-290,000 |
0 |
10.132 |
N/A |
|
|
ASLN |
Aslan Pharmaceuticals Ltd |
68 |
- |
$0.57 |
$548,000 |
1,049,999 |
0.01% |
-1,394,000 |
0 |
0.807 |
N/A |
|
|
RZLT |
Rezolute, Inc |
69 |
- |
$2.92 |
$189,000 |
190,815 |
0% |
-63,000 |
0 |
0.568 |
N/A |
|
